Biocryst Pharmaceuticals (BCRX) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.38
-0.31
-0.24
-0.17

Details

Expected EPS
-0.25
Actual EPS
-0.24
Surprise EPS
0.01
Surprise Percent
+4%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -0.24 per share for Q2 2023.

0 Comments

Share your thoughts